Current status and performance goals for serum thyrotropin (TSH) assays

Clinical Chemistry

Volumn 42, Issue 1, 1996, Pages 140-145

  Spencer, Carole A ^a   Takeuchi, Michael ^a   Kazarosyan, Margarita ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

functional sensitivity; immunoassays

Indexed keywords

THYROTROPIN;

CONFERENCE PAPER; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; LABORATORY; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE;

EID: 0030034886     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.1.140     Document Type: Conference Paper

References (40)

1. Hershman J. Utility of the radioimmunoassay of serum thyrotropin in man. Ann Intern Med 1971;74:481-90.
2. Mayberry WE, Gharib H, Bilstad JM, Sizemore GW. Radioimmunoassay for human thyrotropin. Ann Intern Med 1971;74:471-80.
3. Spencer CA, LoPresti JS, Patel A, Guttler RB, Eigen A, Shen D, et al. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab 1990;70:453-60.
4. Spencer CA, Takeuchi M, Kazarosyn M, MacKenzie F, Beckett GJ, Wilkinson E. Interlaboratory/intermethod differences in functional sensitivity of immunometric assays for thyrotropin (TSH): impact on reliability of measurement of subnormal concentration. Clin Chem 1995;41:367-74.
5. Spencer CA, Schwarzbein D, Guttler RB, LoPresti JS, Nicoloff JT. TRH stimulation test responses employing third and fourth generation TSH assays. J Clin Endocrinol Metab 1993;76:494-8.
6. Rodbard D. Statistical estimation of the minimal detectable concentration ("sensitivity") for radioligand assays. Anal Biochem 1978;90:1-12.
7. Hay ID, Bayer MF, Kaplan MM, Klee GG, Larsen PR, Spencer CA. American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. Clin Chem 1991;37:2002-8.
8. 4 estimate or sensitive TSH measurement. J Clin Immunoassay 1989;12:82-9.
9. Nicoloff JT, Spencer CA. The use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab 1990;71:553-8.
10. Fraser CG, Petersen PH. Desirable standards for laboratory tests if they are to fulfill medical needs. Clin Chem 1993;39:1447-55.
11. Spencer CA, Lum SMC, Wilber JF, Kaptein EM, Nicoloff JT. Dynamics of serum thyrotropin and thyroid hormone changes in fasting. J Clin Endocrinol Metab 1983;56:883-8.
12. Spencer CA, Lai Rosenfeld A, Guttler RB, LoPresti J, Marcus AO, Nimalasuriya A, et al. Thyrotropin secretion in thyrotoxic and thyroxine-treated patients: assessment by a sensitive immunoen zymometric assay. J Clin Endocrinol Metab 1986;63:349-55.
13. Spencer CA, Eigen A, Shen D, Duda M, Qualls S, Weiss S, et al. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 1987;33: 1391-6.
14. Gaines Das RE, Bristow AF. The Second International Reference Preparation of thyroid-stimulating hormone, for immunoassay: calibration by bioassay and immunoassay in an international collaborative study. J Endocrinol 1985;104:367-79.
15. Wilkinson E, Rae P, Thomson K, Toft A, Spencer C, Beckett G. Chemiluminescent third-generation assay (Amerlite TSH-30) of thyroid-stimulating hormone in serum or plasma assessed. Clin Chem 1993;39:2166-73.
16. Boscato LM, Stuart MC. Heterophilic antibodies: a problem for all immunoassays. Clin Chem 1988;34:27-33.
17. Laurberg P. Persistent problems with the specificity of immunometric TSH assays. Thyroid 1993;4:279-83.
18. Spencer CA, LoPresti JS, Nicoloff JT, Dlott R, Schwarzbein D. Multiphasic TSH responses to thyroid hormone administration in man. J Clin Endocrinol Metab 1995;80:854-9.
19. Miles LEM, Hales CN. Labeled antibodies and immunological assay systems. Nature 1968;219:186-9.
20. Taimela E, Tahtela R, Koskinen P, Nuutila P, Forsstrom J, Taimela S, et al. Ability of two new thyrotropin (TSH) assays to separate hyperthyroid patients from euthyroid patients with low TSH. Clin Chem 1994;40:101-5.
21. Woodhead JS, Addison GM, Hales CN. The immunoradiometric assay and related techniques. Br Med Bull 1974;30:44-9.
22. Seth JH, Caldwell G, Sweeting VM, Beckett GJ, Gow SM, Toft AD. A sensitive immunoradiometric assay for serum thyroid stimulating hormone: a replacement for the thyrotropin releasing test. Br Med J 1984;289:1334-6.
23. Weeks I, Sturgess ML, Woodhead JS. Chemiluminescence immunoassay: an overview. Clin Sci 1986;70:403-8.
24. Sadler WA, van der Splinter TM, Murray LM, Turner JG. Calibration of automated thyrotropin assays [Letter]. Clin Chem 1993;39: 904-5.
25. McCapra F, Watmore D, Sumun F, Patel A, Beheshti I, Ramakrishnan K, et al. Luminescent labels for immunoassay - from concept to practice. J Biolumin Chemilumin 1989;4:51-8.
26. Cole TG, Johnson D, Eveland BJ, Nahm MH. Cost-effective method for detection of "hook effect" in tumor marker immunometric assays [Letter]. Clin Chem 1993;39:695-6.
27. Bayer M. Performance criteria for appropriate characterization of "(highly) sensitive" thyrotropin assays [Letter]. Clin Chem 1987; 33:630-1.
28. Spencer C. Further developments in TSH technology. Exp Clin Endocrinol 1994;102:12-22.
29. Magner JA, Kane J, Chou ET, Intravenous thyrotropin (TSH)-releasing hormone releases human TSH that is structurally different from basal TSH. J Clin Endocrinol Metab 1992;74:1306-11.
30. Trojan J, Schaaf L, Weis G, Bergmann A, Helton TE, Magner JA, et al. Isolation and characterization of different subfractions of human serum thyrotropin (hTSH). Exp Clin Endocrinol 1994;102: 33-7.
31. Persani L, Asteria C, Beck-Peccoz P. Dissociation between immunological and biological activities of circulating TSH. Exp Clin Endocrinol 1994;102:38-48.
32. Persani L, Asteria C, Tonacchera M, Vitti P, Krishna V, Chatterjee K, Beck-Peccoz P. Evidence for the secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. J Clin Endocrinol Metab 1994;78:1035-9.
33. Kricka LJ, Schmerfeldd-Pruss D, Senior M, Goodman DB, Kaladas P. Interference by human anti-mouse antibody in two-site immunoassays. Clin Chem 1990;36:892-4.
34. Wickus GG, Mordan RJ, Mathews EA. Interference in the Allégro immunoassay system when blood is collected in silicone-coated tubes [Letter]. Clin Chem 1992;38:2347-8.
35. Becker DV, Bigos ST, Gaitan E, Morris JC, Rallison ML, Spencer CA, et al. Optimal use of blood tests for assessment of thyroid function [Letter]. JAMA 1993;269:2736.
36. Spencer C, LoPresti J, Middlesworth LV, Wartofsky L, Becker DV, Bigos ST, et al. Screening for thyroid dysfunction: which test is best [Reply]? JAMA 1993;270:2297-8.
37. Biondi B, Fazio S, Carella C, Sabatini D, Amato G, Cittadini A, et al. Control of adrenergic overactivity by B-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1994;78: 1028-33.
38. Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995;273:808-12.
39. Franklyn JA, Black EG, Betteridge K, Sheppard MC. Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness. J Clin Endocrinol Metab 1994;78:1368-71.
40. 3 challenge test (T3CT) [Abstract]. J Investig Med 1995;43:107A.